sumatriptan has been researched along with naproxen in 86 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (2.33) | 18.2507 |
2000's | 26 (30.23) | 29.6817 |
2010's | 55 (63.95) | 24.3611 |
2020's | 3 (3.49) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Grotemeyer, KH | 1 |
Rambhau, D; Rao, BR; Rao, YM; Srinivasu, P | 1 |
Krymchantowski, AV | 1 |
Barbosa, JS; Krymchantowski, AV | 1 |
Kajantie, E; Somer, M | 1 |
Morillo, LE | 2 |
Alexander, WJ; Littlefield, DE; Smith, TR; Spruill, SE; Stark, SR; Sunshine, A | 1 |
Cady, R; Schreiber, C | 1 |
Alexander, WJ; Cady, RK; Frishberg, BM; Kori, SH; Lener, SE; Ruoff, GE; Winner, P; Zhang, Y | 1 |
Adelman, JU; Alexander, WJ; Barrett, PS; Brandes, JL; Kudrow, D; Lener, SE; O'Carroll, CP; O'Donnell, FJ; Spruill, SE; Stark, SR | 1 |
Masić, I; Musić, M | 1 |
Hill, KP; Hope, O | 1 |
Kreutzkamp, B | 1 |
Ames, MH; Burch, SP; DeRossett, SE; Landy, S; McDonald, SA; Rapoport, A; Rothrock, J | 1 |
Rothrock, JF | 1 |
Ames, MH; Byrd, SC; Couch, JR; Goldstein, J; Lener, SE; Mannix, LK; McDonald, SA; Silberstein, SD; Toso, C | 1 |
Cleves, C; Tepper, SJ | 1 |
Adelman, JU; Dodick, DW; Kaniecki, RG; Lener, SE; Lipton, RB; Nelsen, AC; White, JD | 1 |
Lockwood, AH | 1 |
Bukenya, D; Derosier, FJ; Landy, S; Lener, SE; Mathew, NT; Stark, S; Tietjen, GE; White, J | 1 |
Cady, RK; Derosier, FJ; Diamond, ML; Lener, SE; Mannix, LK; Martin, VT; McDonald, SA; White, JD | 1 |
Haberer, LJ; Lener, SE; McDonald, SA; Taylor, DR; Walls, CM | 1 |
Bijur, PE; Dua, N; Esses, D; Friedman, BW; Gallagher, EJ; Heins, A; Hochberg, M; Lipton, RB; Sasso, P; Solorzano, C; Xia, S | 1 |
Cady, R; Derosier, F; Durham, PL; Martin, V; McDonald, S; Vause, CV | 1 |
Couch, JR; Khoury, CK | 1 |
Bhojraj, S; Hiremath, VB; Kaliaperumal, K; Nanjan, MJ | 1 |
Berges, A; Lener, SE; McDonald, SA; Walls, C | 1 |
Arsura, E; Sethi, NK; Torgovnick, J | 1 |
Ballard, JE; Cady, RK; Derosier, FJ; Diamond, ML; Diamond, MP; Dorner, DP; Lener, ME; McDonald, SA; Runken, MC; White, J | 1 |
Banks, J; Bennett, N; Cady, R; Farmer, K; Goldstein, J; Juhász, M; Landy, SH; Nett, RB; Runken, MC; Ruoff, GE; Tarrasch, J; Turner, IM | 1 |
Derosier, FJ; Hershey, AD; Lewis, D; Linder, SL; McDonald, SA; Pearlman, E; Richard, NE; Rothner, D; Runken, MC; Winner, PK | 1 |
Hoagland, NA; Hoagland, R; Landy, S | 1 |
Allais, G; Benedetto, C; Castagnoli Gabellari, I; Rolando, S | 1 |
Cady, R; Derosier, F; Krishen, A; Peykamian, M; Ruoff, G; Sheftell, F; Silberstein, S | 1 |
Adams, BE; Derosier, FJ; Goodman, DK; Thompson, AH; White, WB | 1 |
Durham, PL; Vause, CV | 1 |
Blumenfeld, A; Cady, R; Gennings, C | 1 |
Derosier, FJ; Goodman, DK; Granberry, WK; Hershey, AD; Jimenez, TB; Lewis, D; Linder, SL; Pearlman, E; Rothner, AD; Runken, MC; Winner, PK | 1 |
Patel, DP; Sanyal, M; Sharma, P; Shrivastav, PS; Singhal, P | 1 |
Adewumni, V; Bijur, PE; Campbell, CM; Esses, D; Friedman, BW; John Gallagher, E; Lipton, RB; Norton, J; Solomon, S; Solorzano, C | 1 |
Fox, AW | 1 |
Browning, R; Cady, RK; Edwards, KR; Farmer, KU; Rosenthal, BL | 1 |
Dash, PD; Gower, BA; Hammond, ER; Haythornthwaite, JA; Peterlin, BL; Tepper, SJ; Tietjen, GE; Ward, TN; White, LW | 1 |
Yang, LP | 1 |
Beach, ME; Cady, R; Dexter, K; Freitag, F; Manley, HR; Nett, R | 1 |
Cady, R; Dexter, K; Freitag, F; O'Carroll, P; Shade, CL | 1 |
Berka, P; Čižinská, L; Doležal, P; Musilová, M; Stránská, D; Vrbata, P | 1 |
Cady, RK; Landy, SH; Nelsen, A; Runken, MC; White, J | 1 |
Aurora, S; Derosier, F; Goldstein, J; Lener, SE; Lipton, RB; McDonald, SA; Runken, MC; Saiers, J; Silberstein, S; White, J | 1 |
Derry, S; Law, S; Moore, RA | 3 |
Chessman, AW | 1 |
Ballard, J; Derosier, FJ; Diamond, MP; Krishen, A; Lener, SE; Mannix, LK; Martin, VT; McDonald, SA | 1 |
Borghi, L; Lippi, G; Mattiuzzi, C; Meschi, T; Targher, G | 1 |
Calhoun, AH; Ford, S | 1 |
Bendtsen, L; Schytz, HW | 1 |
Bell, CF; Bowers, B; D'Souza, A; Eaddy, M; Goodwin, B; Runken, MC; Shah, M | 1 |
Diener, HC | 1 |
Chai, NC; Dash, PD; Gelaye, B; Gower, BA; Peterlin, BL; Scher, AI; Tietjen, GE; Ward, TN; White, LW | 1 |
Hershey, AD; Linder, S; Winner, P | 1 |
Karakam, VS; Patel, PN; Ragampeta, S; Samanthula, G | 1 |
Syed, YY | 1 |
Bellorio, KB; Brêtas, CM; Brêtas, JM; César, IC; Mundim, IM; Pianetti, GA; Teixeira, Lde S | 1 |
Bhambri, R; Chan, K; Donnet, A; Druyts, E; Goadsby, PJ; Ramos, E; Stark, R; Thorlund, K; Toor, K; Wu, P | 1 |
Bollinger, L; Cangialose, C; Chia, V; Mikol, DD; Xue, F; Yusuf, A | 1 |
Barmettler, G; Becerra, L; Bishop, J; Borsook, D; Burstein, R; Chang, PC; Kainz, V | 1 |
Billinghurst, L; Gersz, EM; Gloss, D; Hershey, AD; Holler-Managan, Y; Leininger, E; Licking, N; Mack, K; Oskoui, M; Potrebic, S; Pringsheim, T; Sowell, M; Victorio, MC; Yonker, M; Zanitsch, H | 1 |
Beitollahi, H; Dourandish, Z; Jahani, PM; Sharifi, F; Tajik, S | 1 |
Agrawal, A; Chanchlani, R; Hafsa, SN; Janjua, D | 1 |
Csáti, A; Szok, D; Tajti, J | 1 |
18 review(s) available for sumatriptan and naproxen
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Migraine headache.
Topics: Acute Disease; Adult; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Child; Diclofenac; Drug Therapy, Combination; Ergotamine; Humans; Ibuprofen; Indoles; Migraine Disorders; Naproxen; ortho-Aminobenzoates; Oxazolidinones; Piperidines; Pyrrolidines; Salicylates; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2003 |
Migraine headache.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Ergotamine; Humans; Ibuprofen; Indoles; Migraine Disorders; Naproxen; ortho-Aminobenzoates; Oxazolidinones; Piperidines; Pyrrolidines; Salicylates; Sumatriptan; Triazoles; Tryptamines | 2004 |
Sumatriptan: update and review.
Topics: Animals; Cardiovascular Diseases; Drug Interactions; Drug Tolerance; Humans; Naproxen; Sumatriptan; Treatment Outcome | 2006 |
Sumatriptan/naproxen sodium combination for the treatment of migraine.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Drug Combinations; Humans; Migraine Disorders; Naproxen; Serotonin Receptor Agonists; Sumatriptan | 2008 |
Sumatriptan-naproxen fixed combination for acute treatment of migraine: a critical appraisal.
Topics: Clinical Trials as Topic; Drug Combinations; Humans; Migraine Disorders; Naproxen; Sumatriptan | 2010 |
Evaluation of the use of sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea.
Topics: Dysmenorrhea; Female; Humans; Menstrual Cycle; Migraine Disorders; Naproxen; Prostaglandins; Serotonin 5-HT1 Receptor Agonists; Sumatriptan | 2011 |
Pharmacological synergy: the next frontier on therapeutic advancement for migraine.
Topics: Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Drug Synergism; Drug Therapy, Combination; Humans; Migraine Disorders; Naproxen; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Tryptamines; World Health Organization | 2012 |
Sumatriptan/naproxen sodium: a review of its use in adult patients with migraine.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Drug Combinations; Drug Therapy, Combination; Humans; Middle Aged; Migraine Disorders; Naproxen; Pain; Randomized Controlled Trials as Topic; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Treatment Outcome | 2013 |
Naproxen with or without an antiemetic for acute migraine headaches in adults.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Drug Therapy, Combination; Humans; Migraine Disorders; Naproxen; Nausea; Piperidines; Randomized Controlled Trials as Topic; Sumatriptan; Tryptamines; Vomiting | 2013 |
Sumatriptan plus naproxen for acute migraine attacks in adults.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Drug Combinations; Drug Therapy, Combination; Humans; Migraine Disorders; Naproxen; Randomized Controlled Trials as Topic; Serotonin 5-HT1 Receptor Agonists; Sumatriptan | 2013 |
Adiponectin and migraine: systematic review of clinical evidence.
Topics: Adiponectin; Adult; Comorbidity; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Migraine Disorders; Naproxen; Obesity; Sumatriptan | 2014 |
Sumatriptan/Naproxen Sodium: A Review in Migraine.
Topics: Drug Combinations; Humans; Migraine Disorders; Naproxen; Sumatriptan | 2016 |
Sumatriptan plus naproxen for the treatment of acute migraine attacks in adults.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Drug Combinations; Drug Therapy, Combination; Humans; Migraine Disorders; Naproxen; Randomized Controlled Trials as Topic; Serotonin 5-HT1 Receptor Agonists; Sumatriptan | 2016 |
Comparative tolerability of treatments for acute migraine: A network meta-analysis.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Migraine Disorders; Naproxen; Sumatriptan; Treatment Outcome; Tryptamines | 2017 |
Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.
Topics: Academies and Institutes; Adolescent; Child; Drug Combinations; Headache; Humans; Migraine Disorders; Naproxen; Neurology; Practice Guidelines as Topic; Research Report; Societies, Medical; Sumatriptan; Treatment Outcome; United States | 2019 |
The Efficacy of Different Triptans for the Treatment of Acute Headache in Pediatric Migraine: A Systematic Review.
Topics: Adolescent; Child; Headache; Humans; Migraine Disorders; Naproxen; Sumatriptan; Tryptamines | 2023 |
[Sumatriptan-naproxen sodium fix-dose combination for acute migraine treatment, a review].
Topics: Double-Blind Method; Drug Therapy, Combination; Headache; Humans; Migraine Disorders; Naproxen; Quality of Life; Sodium; Sumatriptan; Tryptamines | 2023 |
32 trial(s) available for sumatriptan and naproxen
Article | Year |
---|---|
Lack of pharmacokinetic interaction between sumatriptan and naproxen.
Topics: Adult; Biological Availability; Chromatography, High Pressure Liquid; Circadian Rhythm; Cyclooxygenase Inhibitors; Drug Interactions; Humans; Male; Naproxen; Serotonin Receptor Agonists; Sumatriptan; Time Factors | 2000 |
Naproxen sodium decreases migraine recurrence when administered with sumatriptan.
Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Migraine Disorders; Naproxen; Prospective Studies; Recurrence; Serotonin Receptor Agonists; Sumatriptan | 2000 |
Sumatriptan and naproxen sodium for the acute treatment of migraine.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Fatigue; Female; Humans; Male; Middle Aged; Migraine Disorders; Naproxen; Prospective Studies; Serotonin Receptor Agonists; Sumatriptan; Tinnitus; Treatment Outcome | 2005 |
Twelve-month tolerability and safety of sumatriptan-naproxen sodium for the treatment of acute migraine.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Male; Middle Aged; Migraine Disorders; Naproxen; Sumatriptan; Treatment Refusal; Vasoconstrictor Agents | 2007 |
Sumatriptan-naproxen for acute treatment of migraine: a randomized trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Migraine Disorders; Naproxen; Sumatriptan; Tablets; Vasoconstrictor Agents | 2007 |
Two double-blind, multicenter, randomized, placebo-controlled, single-dose studies of sumatriptan/naproxen sodium in the acute treatment of migraine: function, productivity, and satisfaction outcomes.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Double-Blind Method; Drug Combinations; Humans; Male; Middle Aged; Migraine Disorders; Naproxen; Patient Satisfaction; Placebo Effect; Prevalence; Risk Assessment; Risk Factors; Sumatriptan; Treatment Outcome; United States | 2007 |
Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine.
Topics: Adult; Aged; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Migraine Disorders; Naproxen; Nausea; Sumatriptan; Treatment Outcome | 2008 |
Consistency of response to sumatriptan/naproxen sodium in a placebo-controlled, crossover study.
Topics: Adolescent; Adult; Aged; Cross-Over Studies; Cyclooxygenase Inhibitors; Female; Humans; Incidence; Male; Middle Aged; Migraine Disorders; Naproxen; Pain Measurement; Placebo Effect; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; United States; Young Adult | 2009 |
Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
Topics: Adolescent; Adult; Aged; Cross-Over Studies; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Female; Half-Life; Humans; Male; Middle Aged; Migraine Disorders; Naproxen; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines; Young Adult | 2009 |
Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: two randomized controlled trials.
Topics: Administration, Oral; Adult; Double-Blind Method; Drug Combinations; Dysmenorrhea; Female; Humans; Migraine Disorders; Naproxen; Sumatriptan | 2009 |
Distinct pharmacokinetic profile and safety of a fixed-dose tablet of sumatriptan and naproxen sodium for the acute treatment of migraine.
Topics: Acute Disease; Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Compounding; Drug Synergism; Female; Humans; Inflammation; Male; Middle Aged; Migraine Disorders; Naproxen; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Treatment Outcome | 2010 |
Treating headache recurrence after emergency department discharge: a randomized controlled trial of naproxen versus sumatriptan.
Topics: Adult; Analgesics; Double-Blind Method; Emergency Service, Hospital; Female; Headache; Humans; Male; Migraine Disorders; Migraine without Aura; Naproxen; Pain Measurement; Patient Discharge; Secondary Prevention; Sumatriptan; Treatment Outcome | 2010 |
Changes in salivary prostaglandin levels during menstrual migraine with associated dysmenorrhea.
Topics: Adult; Double-Blind Method; Dysmenorrhea; Female; Humans; Middle Aged; Migraine Disorders; Naproxen; Premenstrual Syndrome; Prostaglandins; Saliva; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Young Adult | 2010 |
Pharmacokinetics and tolerability of sumatriptan after single-dose administration of a fixed-dose combination tablet of sumatriptan/naproxen sodium 85/500 mg followed two hours later by subcutaneous sumatriptan 4- or 6-mg injection: a randomized, open-lab
Topics: Administration, Oral; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Blood Pressure; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Combinations; Electrocardiography; Female; Half-Life; Humans; Injections, Subcutaneous; Male; Middle Aged; Naproxen; Serotonin Receptor Agonists; Sumatriptan; Young Adult | 2010 |
Sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomes.
Topics: Adult; Analgesics; Double-Blind Method; Drug Combinations; Dysmenorrhea; Female; Humans; Migraine Disorders; Naproxen; Patient Satisfaction; Premenstrual Syndrome; Sumatriptan | 2011 |
Multi-center comparison of response to a single tablet of sumatriptan 85 mg and naproxen 500 mg vs usual therapy treating multiple migraine attacks as measured by the completeness of response survey.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy, Combination; Female; Health Surveys; Humans; Male; Middle Aged; Migraine with Aura; Migraine without Aura; Naproxen; Recovery of Function; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Young Adult | 2011 |
Long-term evaluation of sumatriptan and naproxen sodium for the acute treatment of migraine in adolescents.
Topics: Acute Disease; Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Migraine Disorders; Naproxen; Sumatriptan; Treatment Outcome; Vasoconstrictor Agents | 2011 |
Sumatriptan-naproxen migraine efficacy in allodynic patients: early intervention.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Disability Evaluation; Drug Therapy, Combination; Early Medical Intervention; Female; Humans; Hyperalgesia; Male; Middle Aged; Migraine Disorders; Naproxen; Prospective Studies; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Treatment Outcome; Young Adult | 2012 |
Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
Topics: Adolescent; Adult; Aged; Barbiturates; Cross-Over Studies; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Migraine Disorders; Naproxen; Sumatriptan; Young Adult | 2012 |
Evaluation of the migraine treatment sumatriptan/naproxen sodium on blood pressure following long-term administration.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Confidence Intervals; Double-Blind Method; Drug Therapy, Combination; Female; Health Status Indicators; Humans; Hypertension; Logistic Models; Male; Migraine Disorders; Naproxen; Risk Factors; Serotonin Receptor Agonists; Sumatriptan; Time Factors | 2011 |
Randomized trial of sumatriptan and naproxen sodium combination in adolescent migraine.
Topics: Adolescent; Child; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Migraine Disorders; Naproxen; Pain Measurement; Placebos; Single-Blind Method; Sumatriptan; Treatment Outcome | 2012 |
A randomized controlled trial of a comprehensive migraine intervention prior to discharge from an emergency department.
Topics: Adult; Emergency Service, Hospital; Female; Headache; Humans; Male; Middle Aged; Migraine Disorders; Naproxen; Patient Discharge; Severity of Illness Index; Sumatriptan; Treatment Outcome | 2012 |
Efficacy, end points and eventualities: sumatriptan/naproxen versus butalbital/paracetamol/caffeine in the treatment of migraine.
Topics: Acetaminophen; Barbiturates; Caffeine; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Endpoint Determination; Humans; Migraine Disorders; Naproxen; Severity of Illness Index; Sumatriptan; Treatment Outcome | 2012 |
Evaluation of sumatriptan-naproxen in the treatment of acute migraine: a placebo-controlled, double-blind, cross-over study assessing cognitive function.
Topics: Adult; Analgesics; Cognition; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Migraine Disorders; Naproxen; Sumatriptan | 2013 |
Ictal adiponectin levels in episodic migraineurs: a randomized pilot trial.
Topics: Adiponectin; Adult; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Body Composition; Cholesterol; Double-Blind Method; Female; Gonadal Steroid Hormones; Humans; Insulin; Middle Aged; Migraine Disorders; Molecular Weight; Naproxen; Neurologic Examination; Pain Measurement; Pilot Projects; Retrospective Studies; Sumatriptan; Surveys and Questionnaires; Vasoconstrictor Agents; Young Adult | 2013 |
Treatment of chronic migraine: a 3-month comparator study of naproxen sodium vs SumaRT/Nap.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Double-Blind Method; Drug Combinations; Humans; Middle Aged; Migraine Disorders; Naproxen; Pilot Projects; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Treatment Outcome; Young Adult | 2014 |
SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Migraine Disorders; Naproxen; Pilot Projects; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Young Adult | 2014 |
Consistency of return to normal function, productivity, and satisfaction following migraine attacks treated with sumatriptan/naproxen sodium combination.
Topics: Adult; Analgesics; Cross-Over Studies; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Migraine Disorders; Naproxen; Patient Satisfaction; Sumatriptan | 2014 |
Sumatriptan/naproxen sodium for the acute treatment of probable migraine without aura: a randomized study.
Topics: Adult; Analgesics; Double-Blind Method; Drug Combinations; Female; Humans; Male; Migraine without Aura; Naproxen; Sumatriptan; Treatment Outcome | 2014 |
Double-blind, placebo-controlled, crossover study of early-intervention with sumatriptan 85/naproxen sodium 500 in (truly) episodic migraine: what's neck pain got to do with it?
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Linear Models; Male; Migraine Disorders; Naproxen; Neck Pain; Pain Measurement; Recurrence; Sumatriptan; Time Factors; Treatment Outcome | 2014 |
Ictal adipokines are associated with pain severity and treatment response in episodic migraine.
Topics: Adipokines; Adult; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Migraine Disorders; Naproxen; Placebos; Severity of Illness Index; Sumatriptan; Treatment Outcome; Vasoconstrictor Agents | 2015 |
Consistency of response to sumatriptan/naproxen sodium in a randomized placebo-controlled, cross-over study for the acute treatment of migraine in adolescence.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Child; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Migraine Disorders; Naproxen; Pain Measurement; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Treatment Outcome | 2015 |
36 other study(ies) available for sumatriptan and naproxen
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[Diagnosis and therapy of migraine].
Topics: Humans; Migraine Disorders; Naproxen; Stress, Psychological; Sumatriptan | 1994 |
New "triptans" and other drugs for migraine.
Topics: Adrenergic beta-Antagonists; Amitriptyline; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Calcium Channel Blockers; Dihydroergotamine; Drug Interactions; Ergotamine; Humans; Indoles; Methysergide; Migraine Disorders; Naproxen; Oxazoles; Oxazolidinones; Piperidines; Propranolol; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Timolol; Triazoles; Tryptamines; Valproic Acid; Vasoconstrictor Agents | 1998 |
Dexamethasone decreases migraine recurrence observed after treatment with a triptan combined with a nonsteroidal anti-inflammatory drug.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Dexamethasone; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Migraine Disorders; Naproxen; ortho-Aminobenzoates; Prospective Studies; Secondary Prevention; Serotonin Receptor Agonists; Sumatriptan | 2001 |
Bilateral cleft lip and palate, hypertelorism and hypoplastic toes.
Topics: Abnormalities, Multiple; Adrenergic beta-Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Bisoprolol; Cleft Lip; Cleft Palate; Female; Foot Deformities, Congenital; Humans; Hypertelorism; Infant; Male; Maternal Exposure; Naproxen; Pregnancy; Sumatriptan; Vasoconstrictor Agents | 2004 |
[Electroencephalographic changes in headaches under the influence of pharmaceuticals].
Topics: Adolescent; Adult; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Electroencephalography; Female; Humans; Male; Middle Aged; Naproxen; Sumatriptan; Vascular Headaches; Vasoconstrictor Agents | 2007 |
Combination of sumatriptan and naproxen for migraine.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Drug Combinations; Drug Therapy, Combination; Humans; Migraine Disorders; Naproxen; Sumatriptan; Tablets; Vasoconstrictor Agents | 2007 |
[Acute migraine. Sumatriptan-naproxen combination tablets work better than a single substance].
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Drug Combinations; Humans; Migraine Disorders; Naproxen; Serotonin Receptor Agonists; Sumatriptan | 2007 |
Images from headache: a costly attack of migraine.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Brain; Drug Therapy, Combination; Electrocardiography; Emergency Service, Hospital; Female; Hematologic Tests; Humans; Migraine Disorders; Naproxen; Promethazine; Serotonin Receptor Agonists; Sumatriptan; Tomography, X-Ray Computed | 2008 |
A fixed-dose combination of sumatriptan and naproxen for migraine.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Drug Combinations; Humans; Migraine Disorders; Naproxen; Serotonin Receptor Agonists; Sumatriptan; Tablets; Treatment Outcome | 2008 |
New therapies may ease headache symptoms. A two-drug combo and two kinds of oxygen therapy show promise for relieving migraine and cluster headache pain.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Cluster Headache; Drug Therapy, Combination; Humans; Hyperbaric Oxygenation; Migraine Disorders; Naproxen; Oxygen; Sumatriptan; Vasoconstrictor Agents | 2008 |
Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Drug Combinations; Drug Costs; Drugs, Generic; Humans; Migraine Disorders; Naproxen; Serotonin Antagonists; Sumatriptan | 2009 |
In vitro dissolution profile comparison of an anti-migraine combinational drug in dosage form.
Topics: Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Compounding; Migraine Disorders; Naproxen; Solubility; Sumatriptan; Tablets, Enteric-Coated; Time Factors | 2010 |
Consistency of response to sumatriptan/naproxen sodium in a placebo-controlled cross-over study.
Topics: Conflict of Interest; Cross-Over Studies; Cyclooxygenase Inhibitors; Humans; Migraine Disorders; Naproxen; Placebos; Serotonin Receptor Agonists; Sumatriptan | 2010 |
Identification of cytokines and signaling proteins differentially regulated by sumatriptan/naproxen.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Capsaicin; Cytokines; Drug Combinations; Drug Interactions; Gene Expression Regulation; Male; Naproxen; Protein Array Analysis; Rats; Rats, Sprague-Dawley; Serotonin 5-HT1 Receptor Agonists; Signal Transduction; Sumatriptan; Time Factors; Trigeminal Ganglion; Trigeminal Nucleus, Spinal | 2012 |
Challenges in the simultaneous quantitation of sumatriptan and naproxen in human plasma: application to a bioequivalence study.
Topics: Adult; Chromatography, High Pressure Liquid; Drug Stability; Humans; India; Linear Models; Male; Naproxen; Reproducibility of Results; Sensitivity and Specificity; Sumatriptan; Tandem Mass Spectrometry; Therapeutic Equivalency | 2012 |
Electrospun drug loaded membranes for sublingual administration of sumatriptan and naproxen.
Topics: Administration, Sublingual; Animals; Anti-Inflammatory Agents, Non-Steroidal; Drug Delivery Systems; In Vitro Techniques; Mouth Mucosa; Nanofibers; Naproxen; Sumatriptan; Swine; Vasoconstrictor Agents | 2013 |
ACP Journal Club. Review: Sumatriptan plus naproxen improves acute migraine more than placebo, sumatriptan, or naproxen.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Humans; Migraine Disorders; Naproxen; Serotonin 5-HT1 Receptor Agonists; Sumatriptan | 2014 |
Relief of menstrual symptoms and migraine with a single-tablet formulation of sumatriptan and naproxen sodium.
Topics: Adolescent; Adult; Analgesics; Drug Combinations; Dysmenorrhea; Female; Humans; Logistic Models; Migraine Disorders; Naproxen; Odds Ratio; Premenstrual Syndrome; Randomized Controlled Trials as Topic; Severity of Illness Index; Socioeconomic Factors; Sumatriptan; Time Factors; Treatment Outcome; Young Adult | 2014 |
[Sumatriptan plus naproxen for acute migraine attacks in adults].
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Drug Combinations; Humans; Migraine Disorders; Naproxen; Review Literature as Topic; Serotonin 5-HT1 Receptor Agonists; Sumatriptan | 2014 |
Migraine-related healthcare resource use and costs for subjects prescribed fixed-dose combination sumatriptan/naproxen sodium vs. single-entity oral triptans in a managed care population in the USA.
Topics: Administration, Oral; Adolescent; Adult; Drug Combinations; Female; Health Care Costs; Humans; Male; Managed Care Programs; Middle Aged; Migraine Disorders; Naproxen; Retrospective Studies; Sumatriptan; Tryptamines; Young Adult | 2015 |
[Pregnant women can take triptans].
Topics: Congenital Abnormalities; Female; Humans; Naproxen; Piperidines; Pregnancy; Sumatriptan; Tryptamines | 2014 |
Quality-by-design-based ultra high performance liquid chromatography related substances method development by establishing the proficient design space for sumatriptan and naproxen combination.
Topics: Chromatography, High Pressure Liquid; Drug Combinations; Drug Contamination; Humans; Monte Carlo Method; Naproxen; Quality Control; Sumatriptan; Tablets | 2015 |
Development and validation of an LC-ESI-MS/MS method for the simultaneous quantification of naproxen and sumatriptan in human plasma: application to a pharmacokinetic study.
Topics: Chromatography, Liquid; Humans; Naproxen; Plasma; Sumatriptan; Tandem Mass Spectrometry | 2016 |
Use of existing electronic health care databases to evaluate medication safety in pregnancy: Triptan exposure in pregnancy as a case study.
Topics: Abnormalities, Drug-Induced; Administrative Claims, Healthcare; Adolescent; Adult; Databases, Factual; Drug Combinations; Electronic Health Records; Female; Humans; Infant, Newborn; Migraine Disorders; Naproxen; Piperidines; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prospective Studies; Registries; Retrospective Studies; Sumatriptan; Tryptamines; United States; Young Adult | 2018 |
Modulation of brain networks by sumatriptan-naproxen in the inflammatory soup migraine model.
Topics: Animals; Brain; Drug Combinations; Infusions, Intraventricular; Magnetic Resonance Imaging; Male; Migraine Disorders; Naproxen; Nerve Net; Rats; Rats, Sprague-Dawley; Sumatriptan | 2019 |
Electrochemical Sensor Based on Ni-Co Layered Double Hydroxide Hollow Nanostructures for Ultrasensitive Detection of Sumatriptan and Naproxen.
Topics: Electrochemical Techniques; Electrodes; Hydroxides; Nanostructures; Naproxen; Pharmaceutical Preparations; Spectroscopy, Fourier Transform Infrared; Sumatriptan | 2022 |